Enterprise Value

Metric · Valuation & Market

Displaying items 1-20 of 67 in total

Hecate Energy Fortifies Legal Ranks Ahead of $1.2B Public Debut

Read full article
Hecate Energy Fortifies Legal Ranks Ahead of $1.2B Public Debut

Sovereign Capital Meets the American Billboard: Clear Channel's Pivot

Read full article
Sovereign Capital Meets the American Billboard: Clear Channel's Pivot

Why Global Traders Are Buying the Wellhead: Centalion’s Haynesville Play

Read full article
BriefGlance

Centerspace’s Silence Signals the Rise of a New Housing Juggernaut

Read full article
Centerspace’s Silence Signals the Rise of a New Housing Juggernaut

The Hidden Windfall: How Clariant’s Forced Exit Sparks Strategic Freedom

Read full article
The Hidden Windfall: How Clariant’s Forced Exit Sparks Strategic Freedom

The $2.34B Anchor: Why Grocery Real Estate Defies Market Gravity

Read full article
The $2.34B Anchor: Why Grocery Real Estate Defies Market Gravity

A Hong Kong Printer's Unlikely Bid for Remington Firearms

Read full article
BriefGlance

The AI Valuation Arbitrage: Inside the $55M Bet on Hyperscale Data

Read full article
The AI Valuation Arbitrage: Inside the $55M Bet on Hyperscale Data

Cracking the Code: How Geophysics and Strategic Capital are Rewriting Nevada's Gold Map

Read full article
Cracking the Code: How Geophysics and Strategic Capital are Rewriting Nevada's Gold Map

From Pit to Lab: How Specialty Tech Redefines Minerals Tech's Margins

Read full article
From Pit to Lab: How Specialty Tech Redefines Minerals Tech's Margins

Reefline Capital: A Specialist Spin-Off Bets on America’s Industrial Core

Read full article
Reefline Capital: A Specialist Spin-Off Bets on America’s Industrial Core

Vivmark's 'A' Rating: A Blueprint for Post-Merger REIT Success

Read full article
BriefGlance

Orbit's Losses Widen, But Is a Turnaround on the Horizon?

Read full article
Orbit's Losses Widen, But Is a Turnaround on the Horizon?

ENEOS's $1.3B Texas Gambit: A Play for Global Chemical Dominance

Read full article
ENEOS's $1.3B Texas Gambit: A Play for Global Chemical Dominance

ContextLogic's $850M gChem Buy: A Bet on Industrial Realities

Read full article
BriefGlance

Shareholder Revolt at Andrew Peller Puts Fairfax Deal, Governance to the Test

Read full article
BriefGlance

KKR's $5.7B Bet on MedTech: Inside the Integer Acquisition

Read full article
KKR's $5.7B Bet on MedTech: Inside the Integer Acquisition

Berkshire's Homebuilding Gambit: Forging an $8.5 Billion Housing Giant

Read full article
BriefGlance

Blank Check, Big Tech: Pelican II's $75M Hunt for a Digital Backbone

Read full article
BriefGlance

Instinct Bio’s Nasdaq Bet: A New Model for the Longevity Economy?

Read full article
Instinct Bio’s Nasdaq Bet: A New Model for the Longevity Economy?

Related topics in Valuation & Market